Lixia Diao

23.6k total citations · 2 hit papers
137 papers, 7.6k citations indexed

About

Lixia Diao is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Lixia Diao has authored 137 papers receiving a total of 7.6k indexed citations (citations by other indexed papers that have themselves been cited), including 85 papers in Molecular Biology, 58 papers in Oncology and 42 papers in Cancer Research. Recurrent topics in Lixia Diao's work include RNA modifications and cancer (27 papers), Cancer-related molecular mechanisms research (20 papers) and Cancer Immunotherapy and Biomarkers (17 papers). Lixia Diao is often cited by papers focused on RNA modifications and cancer (27 papers), Cancer-related molecular mechanisms research (20 papers) and Cancer Immunotherapy and Biomarkers (17 papers). Lixia Diao collaborates with scholars based in United States, China and Netherlands. Lixia Diao's co-authors include Leng Han, Jing Wang, Lauren A. Byers, John V. Heymach, Ignacio I. Wistuba, Don L. Gibbons, Gordon B. Mills, Youqiong Ye, John N. Weinstein and Zhao Zhang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Clinical Investigation.

In The Last Decade

Lixia Diao

134 papers receiving 7.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Targeting DNA Damage Response Promotes Antitumor Immunity through STING-Mediated T-cell Activation in Small Cell Lung Cancer

2019 616 citations Triparna Sen, B. Leticia Rodriguez et al. Cancer Discovery profile →
Epithelial–Mesenchymal Transition Is Associated with a Distinct Tumor Microenvironment Including Elevation of Inflammatory Signals and Multiple Immune Checkpoints in Lung Adenocarcinoma

2016 349 citations Yanyan Lou, Lixia Diao et al. Clinical Cancer Research profile →

Peers

Lixia Diao

ONCOL

IMMUN

PRM

Amit Maity United States

Muh‐Hwa Yang Taiwan

Qiongzhu Dong China

Jaime Rodriguez‐Canales United States

Stefano Indraccolo Italy

Rugang Zhang United States

Peter S. Hammerman United States

Kyriakos P. Papadopoulos United States

Antonio Jimeno United States

Glen J. Weiss United States

Amit Maity United States

Lixia Diao

3.4k ×0.8

2.7k ×0.9

ONCOL

1.9k ×0.8

1.0k ×0.7

IMMUN

1.2k ×1.0

PRM

Citations per year, relative to Lixia Diao Lixia Diao (= 1×) peers Amit Maity

Countries citing papers authored by Lixia Diao

Since Specialization

Citations

This map shows the geographic impact of Lixia Diao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lixia Diao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lixia Diao more than expected).

Fields of papers citing papers by Lixia Diao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lixia Diao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lixia Diao. The network helps show where Lixia Diao may publish in the future.

Co-authorship network of co-authors of Lixia Diao

This figure shows the co-authorship network connecting the top 25 collaborators of Lixia Diao. A scholar is included among the top collaborators of Lixia Diao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lixia Diao. Lixia Diao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Chengxuan, Yuan Liu, Mei Luo, et al.. (2024). The pharmacogenomic and immune landscape of snoRNAs in human cancers. Cancer Letters. 605. 217304–217304. 1 indexed citations

Konen, Jessica, B. Leticia Rodriguez, Joshua K. Ochieng, et al.. (2021). Dual Inhibition of MEK and AXL Targets Tumor Cell Heterogeneity and Prevents Resistant Outgrowth Mediated by the Epithelial-to-Mesenchymal Transition in NSCLC. Cancer Research. 81(5). 1398–1412. 24 indexed citations

Jing, Ying, Yongchang Zhang, Jing Wang, et al.. (2021). Association Between Sex and Immune-Related Adverse Events During Immune Checkpoint Inhibitor Therapy. JNCI Journal of the National Cancer Institute. 113(10). 1396–1404. 75 indexed citations

Ramkumar, Kavya, C. Allison Stewart, Kasey R. Cargill, et al.. (2020). AXL Inhibition Induces DNA Damage and Replication Stress in Non–Small Cell Lung Cancer Cells and Promotes Sensitivity to ATR Inhibitors. Molecular Cancer Research. 19(3). 485–497. 38 indexed citations

Sen, Triparna, B. Leticia Rodriguez, Limo Chen, et al.. (2019). Targeting DNA Damage Response Promotes Antitumor Immunity through STING-Mediated T-cell Activation in Small Cell Lung Cancer. Cancer Discovery. 9(5). 646–661. 616 indexed citations breakdown →

Caetano, Mauricio S., Maya Hassane, Amber M. Cumpian, et al.. (2018). Sex specific function of epithelial STAT3 signaling in pathogenesis of K-ras mutant lung cancer. Nature Communications. 9(1). 4589–4589. 51 indexed citations

Ferrarotto, Renata, Robert J. Cardnell, Shirley Y. Su, et al.. (2018). Poly ADP‐ribose polymerase‐1 as a potential therapeutic target in Merkel cell carcinoma. Head & Neck. 40(8). 1676–1684. 9 indexed citations

Sen, Triparna, Pan Tong, Lixia Diao, et al.. (2017). Targeting AXL and mTOR Pathway Overcomes Primary and Acquired Resistance to WEE1 Inhibition in Small-Cell Lung Cancer. Clinical Cancer Research. 23(20). 6239–6253. 101 indexed citations

Balaji, Kavitha, Smruthi Vijayaraghavan, Lixia Diao, et al.. (2016). AXL Inhibition Suppresses the DNA Damage Response and Sensitizes Cells to PARP Inhibition in Multiple Cancers. Molecular Cancer Research. 15(1). 45–58. 70 indexed citations

10.

Wang, Yifan, Hui Liu, Lixia Diao, et al.. (2016). Hsp90 Inhibitor Ganetespib Sensitizes Non–Small Cell Lung Cancer to Radiation but Has Variable Effects with Chemoradiation. Clinical Cancer Research. 22(23). 5876–5886. 27 indexed citations

11.

Lou, Yanyan, Lixia Diao, Edwin R. Parra, et al.. (2016). Epithelial–Mesenchymal Transition Is Associated with a Distinct Tumor Microenvironment Including Elevation of Inflammatory Signals and Multiple Immune Checkpoints in Lung Adenocarcinoma. Clinical Cancer Research. 22(14). 3630–3642. 349 indexed citations breakdown →

12.

Skinner, Heath D., Uma Giri, Liang Yang, et al.. (2016). Proteomic Profiling Identifies PTK2/FAK as a Driver of Radioresistance in HPV-negative Head and Neck Cancer. Clinical Cancer Research. 22(18). 4643–4650. 55 indexed citations

13.

Cardnell, Robert J., Carmen Behrens, Lixia Diao, et al.. (2015). An Integrated Molecular Analysis of Lung Adenocarcinomas Identifies Potential Therapeutic Targets among TTF1-Negative Tumors, Including DNA Repair Proteins and Nrf2. Clinical Cancer Research. 21(15). 3480–3491. 37 indexed citations

14.

Li, Jun, Leng Han, Paul Roebuck, et al.. (2015). TANRIC: An Interactive Open Platform to Explore the Function of lncRNAs in Cancer. Cancer Research. 75(18). 3728–3737. 407 indexed citations

15.

Nilsson, Monique B., Uma Giri, Jayanthi Gudikote, et al.. (2015). KDR Amplification Is Associated with VEGF-Induced Activation of the mTOR and Invasion Pathways but does not Predict Clinical Benefit to the VEGFR TKI Vandetanib. Clinical Cancer Research. 22(8). 1940–1950. 10 indexed citations

16.

Ferrarotto, Renata, Suk Young Yoo, Pan Tong, et al.. (2015). Epithelial–Mesenchymal Transition Predicts Polo-Like Kinase 1 Inhibitor–Mediated Apoptosis in Non–Small Cell Lung Cancer. Clinical Cancer Research. 22(7). 1674–1686. 40 indexed citations

17.

Mazumdar, Tuhina, Lauren A. Byers, Patrick Kwok Shing Ng, et al.. (2014). A Comprehensive Evaluation of Biomarkers Predictive of Response to PI3K Inhibitors and of Resistance Mechanisms in Head and Neck Squamous Cell Carcinoma. Molecular Cancer Therapeutics. 13(11). 2738–2750. 66 indexed citations

18.

Cardnell, Robert J., Ying Feng, Lixia Diao, et al.. (2013). Proteomic Markers of DNA Repair and PI3K Pathway Activation Predict Response to the PARP Inhibitor BMN 673 in Small Cell Lung Cancer. Clinical Cancer Research. 19(22). 6322–6328. 131 indexed citations

19.

Xie, Xuemei, et al.. (2013). Bisphosphorylated PEA-15 Sensitizes Ovarian Cancer Cells to Paclitaxel by Impairing the Microtubule-Destabilizing Effect of SCLIP. Molecular Cancer Therapeutics. 12(6). 1099–1111. 14 indexed citations

20.

Wan, Xinhai, Jie Liu, Vassiliki Tzelepi, et al.. (2012). Activation of β-Catenin Signaling in Androgen Receptor–Negative Prostate Cancer Cells. Clinical Cancer Research. 18(3). 726–736. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact